Aggregate entropy scoring for quantifying activity across endpoints with irregular correlation structure  by Zhang, Guozhu et al.
A
w
G
a
b
c
a
A
R
R
A
A
K
D
C
M
Z
H
T
M
1
c
u
i
o
t
a
e
S
T
r
p
E
t
i
H
U
(
r
h
0Reproductive Toxicology 62 (2016) 92–99
Contents lists available at ScienceDirect
Reproductive  Toxicology
j ourna l ho me pa g e: www.elsev ier .com/ locate / reprotox
ggregate  entropy  scoring  for  quantifying  activity  across  endpoints
ith  irregular  correlation  structure
uozhu  Zhanga, Skylar  Marvela, Lisa  Truongc, Robert  L.  Tanguayc,  David  M.  Reif a,b,∗
Bioinformatics Research Center, North Carolina State University, Raleigh, NC, USA
Department of Biological Sciences, Center for Human Health and the Environment, North Carolina State University, Raleigh, NC, USA
Department of Environmental and Molecular Toxicology, Sinnhuber Aquatic Research Laboratory, Oregon State University, Corvallis, OR, USA
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 30 December 2015
eceived in revised form 23 March 2016
ccepted 15 April 2016
vailable online 27 April 2016
eywords:
evelopmental neurotoxicology
a  b  s  t  r  a  c  t
Robust  computational  approaches  are  needed  to characterize  systems-level  responses  to chemical  pertur-
bations in  environmental  and  clinical  toxicology  applications.  Appropriate  characterization  of  response
presents  a methodological  challenge  when  dealing  with  diverse  phenotypic  endpoints  measured  using
in vivo  systems.  In this  article,  we  propose  an information-theoretic  method  named  Aggregate  Entropy
(AggE)  and  apply  it to scoring  multiplexed,  phenotypic  endpoints  measured  in developing  zebraﬁsh
(Danio  rerio)  across  a broad  concentration-response  proﬁle  for a diverse  set  of 1060  chemicals.  AggE
accurately  identiﬁed  chemicals  with  signiﬁcant  morphological  effects,  including  single-endpoint  effectshemical biology
orphology
ebraﬁsh
igh throughput screening
oxCast
ultiplexed assays
and  multi-endpoint  responses  that  would  have  been  missed  by univariate  methods,  while  avoiding  puta-
tive  false-positives  that confound  traditional  methods  due to irregular  correlation  structure.  By  testing
AggE  in a  variety  of high-dimensional  real and  simulated  datasets,  we  have  characterized  its perfor-
mance  and suggested  implementation  parameters  that can guide  its application  across  a wide range  of
experimental  scenarios.
Published  by  Elsevier  Inc.  This  is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://. Introduction
Biological responses in whole animals are the product of
oordinated actions (or, in the case of toxic responses, dysreg-
lation) on a systemic level. Accordingly, experimental inquiries
nto basic biological processes should record multiple phenotypic
utcomes when assessing perturbations, from clinical interven-
ions such as drug treatments to environmental stressors such
s manufactured chemicals. Innovations in multiplexed endpoint
Abbreviations: MORT, mortality; YSE, yolk sac edema; AXIS, body axis; EYE,
ye; SNOU, snout; JAW, jaw; OTIC, otic vesicle; PE, pericardial edema; BRAI, brain;
OMI, somite; PFIN, pectoral ﬁn; CFIN, caudal ﬁn; PIG, pigment; CIRC, circulation;
RUN, truncated body; SWIM,  swim bladder; NC, notochord & bent tail; TR, touch
esponse; NOAE, no observed adverse effect; AggE, Aggregate Entropy; PP, positive-
ositive; NN, negative-negative; NP, negative-positive; PN, positive-negative; Any
nd, any endpoint; ROC, receiver operating characteristic; hpf, hours post fertiliza-
ion; AOP, adverse outcome pathway; HTS, high throughput screening; MI,  mutual
nformation; SE, super endpoint.
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measurement technology and exploratory omics platforms have
enabled theoretically comprehensive experiments to be conducted
[1]. However, these new, multi-endpoint data present challenges
with respect to recapitulating the relevant biological processes: (1)
The correlation structure across endpoints is irregular; (2) Individ-
ual subjects/samples vary in endpoint presentation; (3) Endpoint
measurement methods are imperfect; (4) Experimental questions
may  depend on subsets and/or recombinations of endpoints. There-
fore, analysis methods are needed that can address these challenges
while allowing for either focused, a priori analysis or data-wide,
empirical analysis.
One such area where comprehensive analysis of systemic
response is needed is environmental and clinical toxicology, where
adverse responses may  manifest anywhere from speciﬁc abnormal-
ities to collections of several endpoints that count as toxicity in the
aggregate. While there is an ever-increasing number of chemicals
in commerce and the environment, comprehensive toxicological
knowledge is lacking for all but a handful of compounds—mostly
pharmaceuticals that have progressed to expensive, late-stage clin-
ical trials. Traditional animal testing is very expensive in terms
of labor, time, and money, so high-throughput screening (HTS) is
being developed in order to more efﬁciently assess chemical bio-
compatibility [2]. Experimental HTS includes both in vitro assays
that probe molecular action and in vivo assays that screen for a
D license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ariety of phenotypic endpoints that cover fundamental develop-
ental, structural, and neurological pathways [3–5].
These HTS in vivo assays provide an ideal workbench for the
evelopment and testing of analysis methods for multiple end-
oints, in that the data can be generated on a scale that permits
valuation of an analysis method’s ability to address the four chal-
enges presented above. In particular, experimental methods for
he zebraﬁsh (Danio rerio), a model organism whose fundamental
evelopmental processes are shared across vertebrates and that
as high genetic similarity to humans, have exploded in recent
ears [6,7]. Several endpoints, ranging from speciﬁc structural fea-
ures through outright mortality, have been measured, with a
rend toward higher-order assessment of multiple endpoints dur-
ng embryonic development [8].
Here, we developed an information theory-based method
amed Aggregate Entropy (“AggE”) to consolidate information
nto classes across endpoints, then tested this method using both
imulated and empirical zebraﬁsh data. We  characterized the rela-
ionship amongst endpoints to identify the biological processes
nderlying overall developmental assessments; used simulated
ata to further validate our method across a range of sample sizes;
haracterized the irregular correlation structure across endpoints
sing mutual information and normalized information distance;
nd used this information to reduce noise by collapsing endpoints
ith similar phenotypic response patterns. Finally, we parameter-
zed AggE distributions to allow for application to new datasets
f varying dimensions from multi-endpoint experiments in any
odel system.
. Materials and methods
.1. Empirical data
The empirical data were collected as described in Truong et al.
5] and Noyes et al. [9]. Fig. 1 shows the experimental design and
ata structure. The data include 1060 unique ToxCast chemicals
ested at six concentrations for each chemical (0 M,  0.0064 M,
.064 M,  0.64 M,  6.4 M and 64 M).  There were n = 32 repli-
ates (individual embryo wells) at each concentration. At 120 h
ost fertilization (hpf), 18 distinct developmental endpoints were
valuated. The data were recorded as binary incidences.
As in Fig. 1(B) and (C), we constructed 19 different biological
tates, including 18 developmental endpoints plus one NOAE (No
bserved Adverse Effect) state. Thus, for each embryo per chemical-
er concentration, data were shown as 0 and 1 for 18 binary
ndpoints with NOAE recorded as 19 −
∑
(BinaryEndpoints) . All
nalysis was performed using R [13].
.2. Aggregate Entropy
The traditional Shannon’s entropy H (X) [14], in nat units, is:
Let X be a discrete random variable with a possible set of real-
zations x, thus;
(X) = −
∑
x
p (x) logep (x)
We  deﬁne a random variable and its realizations as follows:
For each chemical C at a given concentration, let Xi repre-
ent embryo i with i = 1, . . .,  32 and Bj represent biological state j
ithj = 1, . . .,  19.  In addition, Xi has realization xij with its sample
alue shown in Fig. 1. The probability mass function can be written
s:(
Bj|C, Xi
)
= xij
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The Aggregate Entropy (AggE) for chemical C at a given concen-
tration is summarizing the Shannon’s entropy of all tested embryos,
which is:
AggE = −
32∑
i=1
19∑
j=1
p
(
Bj|C, Xi
)
loge
{
p
(
Bj|C, Xi
)}
2.3. Threshold determination
We ﬁrst used a chi square approximation to the distribution of
AggE of each concentration as well as the distribution of the pooled
concentration [15,16]. We  estimated our chi square degree of free-
dom by using the Newton algorithm to optimize the logarithm of
the full likelihood of a chi square probability density function. Let
(AggE1, AggE2, . . .,  AggEN) be a set of AggE, thus the full likelihood
can be written as:
f (AggE1, AggE2, . . .,  AggEN) =
(
1
2
k
2  (k)
)n
×(AggE1 ∗ . . . ∗ AggEN)
k
2 e−
AggE1+...+AggEN
2
where k is the degree of freedom of a Chi-square distribution and
N is the number of chemicals. Since the maximum likelihood esti-
mator is nonlinear, we ﬁrst took the negative logarithm of the full
likelihood. After that, given a start value, we used Newton iteration
to optimize the negative logarithm of the full likelihood such that
it gave us the optimal estimate of the degree of freedom of our chi
square distribution. Our threshold, which depends on the observed
incidences of multiple measurements over many individuals, is the
critical value of a one-sided chi square test with the signiﬁcance
level of 0.05.
2.4. Endpoint clustering and sensitivity analysis
We next used pairwise mutual information to characterize the
relationship among endpoints. Let E1 andE2 represent two end-
points with realization e1and e2as observed incidence counts per
chemical-per concentration, given the Shannon’s entropy deﬁned
above, the joint Shannon’s entropy forE1 and E2 is:
H (E1, E2) = −
∑
e1
∑
e2
p (e1, e2) logep (e1, e2)
And the conditional entropy can be written as:
H (E1|E2) = −
∑
e1
∑
e2
p (e1, e2) logep (e1|e2)
With all these deﬁnitions, the mutual information (MI) is:
MI (E1, E2) =
∑
e1
∑
e2
p (e1, e2) loge
p (e1, e2)
p (e1)p (e2)
= H (E1) −  H (E1|E2)
MI  has the following, commutative, property:
MI (E1, E2) = MI (E2, E1)
We formed our clusters based on a modiﬁed three-step mea-
surement [17]. First, the pairwise mutual information between
endpoints, MI
(
Ei, Ej
)
, i, j = 1, . . .,  18, is calculated by using R
package “infotheo” [18]. Next, the mutual information matrix is
transferred to a distance measurement, called normalized infor-
mation distance [19], which is:d
(
Ei, Ej
)
= 1 −
MI
(
Ei, Ej
)
H (Ei) + H
(
Ej
)
+ MI
(
Ei, Ej
)
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Fig. 1. Experimental Design and Data Structure. (A) Chemical exposure started at 6hpf. At 120 hpf, 18 distinct developmental assessments were measured. (B) 19 biological
states  (developmental assessments plus NOAE) with their abbreviations. (C) Data structure showing three example vectors from n = 32 individual wells per concentration-
by-chemical. X1 indicates many developmental problems observed; X2 shows mortality; X32 represents no phenotypic consequences recorded. (D) Aggregate Entropy, in
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Finally, hierarchical clustering with normalized information dis-
ance and Ward’s method was used to characterize the relationship
etween endpoints.
Our sensitivity analysis followed a three-step procedure. First,
ased on our clustering analysis, we decided which endpoint or
ndpoints (super endpoints) we wanted to remove or collapse.
econd, we recalculated AggE based on the new set of the end-
oints and determined our threshold following the same algorithm
eﬁned above. Third, we calculated the concordance (in at least one
oncentration) between AggE and Fisher’s Exact Test for identifying
evelopmental effects.
.5. Simulation
Given the data structure in Fig. 1, for each endpoint, we simu-
ated a series of Bernoulli trials with sample sizes of 8, 16, 32, 64
nd 96 per chemical-per concentration with the real frequencies
eﬁned as
(x  = 1) =
∑32
i=1xi
32
andp (x = 0) = 1 − p (x = 1)
here xi is the binary incidence for embryo i for the given endpoint.
. Results
As detailed in Methods, AggE was developed using data collected
ccording to the experimental design presented in Fig. 1, where
ach of the 1060 unique chemicals were tested at six concentra-
ions, with n = 32 replicates (wells each containing an individual
mbryo) at each concentration (Truong et al. [5]). Chemical expo-
ure began at 6 h post fertilization (hpf), then all replicates were
valuated for a suite of 18 developmental endpoints at 120 hpf.xis. The black lines connect the concentration-wise AggE for this example chemical,
cance threshold. (For interpretation of the references to colour in this ﬁgure legend,
3.1. Distribution and threshold across concentration for AggE
The histograms of AggE across concentrations are shown in
Fig. 2. Our chi-square approximation is consistent with the ker-
nel density estimate. The distribution shifts to the right as the
concentration increases because we generally observed higher
incidence rates at higher concentrations. According to our thresh-
old for AggE (versus the univariate Fisher’s Exact Test), we found
that 24 (versus 10) chemicals signiﬁcantly affected the develop-
ment of zebraﬁsh at a concentration of 0.0064 M; 25 (versus 15)
chemicals at 0.064 M;  49 (versus 34) chemicals at 0.64 M;  56
(versus 59) chemicals at 6.4 M and 139 (versus 168) chemicals at
64 M.  The consequences of mortality are evident in the differences
between the distributions at 64 M (highest observed mortality)
and the ‘Global’ threshold, which was less sensitive to suppres-
sion of AggE from observed mortality (see discussion of Fig. 3,
below). Table 1 contains information on thresholds and summary
statistics.
3.2. Evaluation of AggE in predicting individual morphological
effects
For each concentration, we  also estimated the general agree-
ment between AggE and Fisher’s Exact Test on speciﬁc endpoints.
We did not include mortality in Fisher’s Exact Test, because if an
embryo was dead, we  could not measure any other endpoints, and
our method was designed to evaluate the hazard information across
endpoints. For our calculations, PP represents tested positive in
both tests; NN represents tested negative in both tests; NP rep-
resents tested negative in AggE and positive in Fisher’s Exact Test
and PN represents the opposite case. The balanced ROC (Receiver
Operating Characteristic) curve, balanced F1 score measurement
2×PP
2×PP+PN+NP and concordance
(PP+NN)
(PP+NN+PN+NP) between the two tests
are shown in Table 1. As an overall summary, the 1060 chemicals are
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Fig. 2. Histogram of AggE across concentrations. The horizontal axis is AggE, and the vertical axis is the density. The blue line is a kernel density estimate, and the red line is
a  chi square approximation. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web  version of this article.)
Table 1
Threshold determination of AggE with multiple evaluations including balanced ROC curve, balanced F1 score and concordance.
Concentration Degree of Freedom
(Chi-square)
Threshold (Q(x > 0.05)) # of Signiﬁcant
Chemicals AggE
(Univariate Test)
Balanced ROC Balanced F1 Score Concordance
0.0064 M 2.60 7.10 24 (10) 0.56 0.20 0.98
0.064  M 2.66 7.21 25 (15) 0.70 0.51 0.98
0.64  M 2.64 7.18 49 (34) 0.73 0.60 0.97
6.4  M 2.94 7.71 56 (59) 0.88 0.81 0.97
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isplayed in decreasing order of their maximum-normalized AggE
core, summed across all concentrations Supplementary Table S1
n the online version at DOI: 10.1016/j.reprotox.2016.04.012 (.csv).
.3. Comparison of AggE with Fisher’s exact test
We  next observed a positive relationship between the numbers
f signiﬁcant endpoints of each chemical identiﬁed by Fisher’s Exact
est and its associated Aggregate Entropy (Fig. 3A). We  found that
ggE is less likely to detect chemicals that cause only mortality,
hich is expected, given that mortality overwrites all speciﬁc end-
oints as zero (see Fig. 1). 12-Benzenedicarboxaldehyde (6.4 M;
4 M) is shown as an example of this particular case (Fig. 3B),
here no concentration-response is evident in the speciﬁc end-
oints, and only mortality is observed at higher concentrations.
hen compared to Fisher’s Exact Test for each speciﬁc endpoint,
ur method is less likely to detect chemicals where the incidence
ate of that endpoint just reaches the signiﬁcance threshold, as8) 0.89 0.81 0.95
with 5-[2-methyl-3-(pyridine-3-yl)-1H-indol-1-yl]pentanoic acid
(Fig. 3B). On the contrary, chemicals having moderate incidence
across several endpoints, yet fail to reach the statistical thresh-
old for any single endpoint are identiﬁed by AggE. These chemicals
have moderate incidence rates across multiple test endpoints and
disproportionately affect certain individuals in the population, pos-
sibly reﬂecting genetic variability or experimental difﬁculty in
pathological annotation of several related endpoints. For example,
many embryos exhibited developmental endpoints when exposed
to Di(2-ethylhexyl) adipate (Fig. 3B); however, none of these inci-
dence rates were signiﬁcant according to univariate criteria, while
from an integration perspective, such a proﬁle warrants concern.
We also constructed a new endpoint named “Any End” to contrast
with AggE. “Any End” represents an observable positive response
in any of the tested endpoints and should thus behave similarly to
the most sensitive speciﬁc endpoint. The Ziram example in Fig. 3B
shows AggE accretion over concentrations displaying several spe-
ciﬁc endpoint responses.
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Fig. 3. (A) Correlation between the number of chemicals associated with signiﬁcant endpoints determined by Fisher’s Exact Test (vertical axis) by AggE (horizontal axis).
From  left to the right, the plots show results for concentrations 0.0064 M, 0.064 M,  0.64 M, 6.4 M and 64 M,  respectively. Red triangle: signiﬁcant mortality and/or
other  speciﬁc endpoint(s); black dot: signiﬁcant endpoint(s) only (except mortality); red line: linear regression ﬁt. (B) similarities and dissimilarities between our method and
Fisher’s Exact Test on each individual endpoint. For the ﬁrst panel of each chemical (AggE): gray line is the cumulative summation of the threshold of AggE by concentration;
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.4. Clustering analysis
As in Truong et al. [5] a pairwise correlation matrix of the
ndpoints based on the lowest effect level shows an irregular corre-
ation surface. Here we use an information theory-based approach
o identify clusters of the endpoints in order to appropriate han-
le correlation stemming from individual zebraﬁsh proﬁles as well
s endpoint relatedness. The pairwise mutual information matrix
s shown in Supplementary Table S3 in the online version at DOI:
0.1016/j.reprotox.2016.04.012. We  next followed the procedures
escribed in the methods section to ﬁnd clusters with similar phe-
otypic responses (Fig. 4A). From both the mutual information
cross endpoints and clustering analysis, notochord distortion (NC),
ent body axis (AXIS), touch response (TR), and mortality (MORT)
eem to be independent of other endpoints. The other 5 clusters
nclude craniofacial endpoints (Eye, Snout and Jaw), edemas (Yolk
ac Edema and Pericardial Edema), upright body (Swim Bladder,
omite and Circulation), Brain (Brain, Otic Vesicle and Pectoral Fin),
nd Trunk (Trunk and Caudal Fin).
We  performed a sensitivity analysis by removing one endpoint
t a time or a cluster of endpoints (SE: Super Endpoints). After
emoving one endpoint at a time, we found that we  do not lose
he power of detecting that particularly removed endpoint due to
he high mutual information shared with any other endpoint(s).
owever, this is not true for removing a single clustered endpoint.
or example, the mutual information for two edema endpoints is
ery high. After removing these two endpoints, we found that we
ost the power of detecting chemicals previously associated with
dema. However, we increase the power of detecting chemicals
hat caused other developmental defects because of the reducedth points colored red that exceed the threshold. For other panels of each chemical:
her’s Exact Test, it turns red. (For interpretation of the references to colour in this
noise of the data caused by the irregular correlation structure. This
trend continues after the same analysis over other super endpoints.
Based on this fact, we  carried out an analysis on our 10 super end-
points (Fig. 4A), which are the 10 clusters deﬁned above. For any
super endpoint that contains more than one single endpoint, if
at least one developmental defect was observed within the same
super endpoint of that embryo, we recorded that this embryo has
this particular defect. For instance, Edema contains two single end-
points (YSE and PE). If one embryo has either one or both, we state
that this embryo has an edema problem. We  compared the balanced
sensitivity, speciﬁcity and F1 score of our method on the new super
endpoints with the original single endpoint in classifying chemicals
that have a signiﬁcant effect on a speciﬁc endpoint based on Fisher’s
Exact Test (Fig. 4B). In general, our method performed better using
super endpoints on any measurement and retained high power
for detection of hazardous chemicals. Since mortality supersedes
recording of speciﬁc developmental endpoints, we also performed
the same analysis after removing mortality, resulting in 17 single
endpoints and 9 super endpoints. In brief, AggE still performed bet-
ter using super endpoints, and we increased the power of detecting
hazardous chemicals that caused signiﬁcant developmental prob-
lems (Fig. 4B). This reﬂects the ﬂexibility of AggE using reduced
endpoint sets, or more general annotation of difﬁcult-to-discern
speciﬁc endpoints (i.e. annotation as “Edema” versus separate YSE
or PE entries).3.5. Simulation
We  explored the applicability of our method to different exper-
imental designs by generating simulated data sets with different
G. Zhang et al. / Reproductive Toxicology 62 (2016) 92–99 97
Fig. 4. (A) Heatmap showing hierarchical clustering using normalized information distance with ward linkage. SE: Super Endpoint. (B) Comparison of the predictive power
of  chemicals that caused signiﬁcant morphological effect by applying our method on single endpoint with mortality (black triangle); without mortality (green diamond) vs.
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ample sizes of n = 8, 16, 32, 64 and 96. We  compared the variation
f our simulated AggEs over the pooled concentration by using vio-
in plots (Fig. 5 Fig. 5). AggE relies on the tested sample size as
ell as observed incidence rates of multiple measurements. Thus,
he degrees of freedom of our chi square approximation to AggE
ncreases with the sample size, because as we attain more embryos,
e increase our hazard information (Supplementary Table S2 in the
nline version at DOI: 10.1016/j.reprotox.2016.04.012). The three
easurements, which are balanced ROC curve, F1 score and con-
ordance, all reach to a comparable stationary phase at the sample
ize of 32 and 64. If the sample size gets too small, balanced ROC
urve and concordance become over-representative. Once the sam-
le size gets too big, all three measurements decrease dramatically
ompared to the raw data measurements in Table 1. In general, we
eed a big sample size to reduce the bias and get a more accurate
stimate. However, in this case, if the sample size gets too big, even a
mall difference of incidence rate between two  experiments can be
igniﬁcant using Fisher’s Exact Test, binomial test, or other uncor-
ected, univariate tests. Thus, these statistical tests on each speciﬁc
ndpoint may  not be appropriate, while AggE is still valid regard-
ess of the sample size and can be appropriately parameterized by
ample size and observed incidences on multiple measurements.
.6. Validation
We  next tested our method based on the results of an exter-
al dataset of ﬂame retardant chemicals [9]. The data structure is
omparable to what we have shown here, with n = 32 and the same
et of endpoints. For chemicals that have the same tested concen-
rations as ours, we used the same threshold concentration-wise
n Table 1. For those chemicals that have different tested concen-
rations (6.4E–6 M, 6.4E–5 M, 6.4E–4 M),  we used the global
hreshold in Table 1. The analysis was redone using Fisher’s Exact
est, and the chemicals showing signiﬁcant morphological effectsat only the super endpoint (red triangle, blue diamond) will be visible for cases of
ity; BF1S: Balanced F1 Score. (For interpretation of the references to colour in this
associated with their effective concentrations are displayed in
Table 2. The results also show a strong agreement between
our method and Fisher’s Exact Test. Our method identiﬁed
three new chemicals (5-OH-BDE-47, BDE100, and TBP) show-
ing evidence of aggregate developmental hazard. There are three
chemicals, DE71 (a mixture of brominated diphenyl ethers) at
64 M, o-TCP (Tri-o-cresyl phosphate) at 64 M and TDCPP
(Tris(1,3-dichloro-2-propyl) phosphate) at 64 M, that did not
reach our AggE threshold but are signiﬁcant according to Fisher’s
Exact Test. o-TCP and TDCPP have a very high mortality rate at
64 M, and DE71 only univariately signiﬁcant on body bent axis.
4. Discussion
We presented a scoring framework called Aggregate Entropy
to evaluate the developmental toxicity of chemicals in vivo. In
terms of sensitivity, AggE is consistent with Fisher’s Exact Test
and other contingency-table methods in many scenarios but has
advantages when presented with interindividual heterogeneity
and endpoint–endpoint correlation. In terms of speciﬁcity, AggE
reduces potentially false-positive signiﬁcance calls arising from
small numbers in any one cell of a contingency table, render-
ing AggE more stable in the face of smaller sample sizes and
single-endpoints. AggE considers the information of all phenotypic
responses of zebraﬁsh after chemical exposure. This aligns with
the logic that if a chemical elicits responses in many of the tested
endpoints, yet none of these singular endpoints reaches the inci-
dence threshold by Fisher’s Exact Test, we should still annotate its
potential hazard. Due to our limited knowledge about the underly-
ing biological processes perturbed by most chemicals, and because
many of the endpoints share elements of the same Adverse Out-
come Pathways (AOPs), these chemicals warrant further scrutiny.
Our clustering analysis and sensitivity analysis indicated that
there is a strong, yet not uniform, relationship among many
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Table  2
Validation of our method using Noyes et al. [9].
Chemical Name Concentration(M)  Signiﬁcant Endpoint(s) Aggregate Entropy
BPDP 64 YSE, AXIS, EYE, SNOU, JAW, PE, PFIN, CFIN 37.91c
mITP 0.64 YSE, AXIS, SNOU, JAW, PE, PFIN, SWIM,  TR 31.78c
IPP-1 64 MORT, YSE, AXIS, PE, PFIN, CFIN, TR 23.32c
IPP-3 64 YSE, AXIS, PE, PFIN, CFIN 20.41c
TBBPA 6.4 MORT, AXIS, JAW, CFIN, TRUN, TR 12.23c
IPP-2 64 YSE, AXIS, PE 10.94b
TCP 64 MORT, YSE, AXIS, PE, TR 10.94b
5-OH-BDE-47 0.00064 None 7.28d
BDE100 0.00064 None 6.43d
TBBPA 64 MORT 6.39d
TDCPP 64 MORT, CFIN 5.92
o-TCP  64 MORT 5.73
TBP  0.0064 None 5.66a
DE 71 64 AXIS 3.3
a Signiﬁcant at 0.1.
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c
mb Signiﬁcant at 0.05.
c Signiﬁcant at 0.001.
d Signiﬁcant at 0.1 using Global Threshold (Concentration does not match).
ndpoints in these data, which is especially common in develop-
ental studies where a coordinated cascade of biological events
ust take place. We  need to have methods that do not inﬂate
alse-positives nor lose power (i.e. inﬂate false-negatives) when
aced with irregular correlation structure. AggE was designed to
olve this problem. Across a diverse chemical set, we can capital-
ze on this correlation structure to hypothesize endpoints related
y common perturbations or adverse outcome pathways. In addi-
ion, we showed the beneﬁts of removing speciﬁc endpoints
hat shared an especially tight correlation structure with other
ndpoint(s). The analysis on 10 super endpoints outperformed
measured by detection of previously-identiﬁed chemical effects)
he results using the full set of original, speciﬁc endpoints. This may
id future experimental design by negating the need to annotate
ifﬁcult-to-separate endpoints into speciﬁc bins or enable imple-
entation of fully-automated annotation protocols.
Our method offers several beneﬁts over common statistical
ethods used in analyzing zebraﬁsh morphological data. First, we
ere able to detect chemicals having robust effects on speciﬁc end-
oints based on Fisher’s Exact Test, as well as many new chemicals
hat would be missed by such traditional methods. Second, AggE
aintains appropriate detection power when faced with extremely
arge or small sample sizes, whereas contingency-table methods
uffer an inﬂation of false-positives. Third, AggE does not enforce a
lobal model, whereas simple linear or logistic ﬁt models will not
e appropriate in data where the variance of the incidence rate is
ot constant and residuals differ across concentrations. Fourth, if
e simply add all of the observed incidences for each embryo then
erform a standard statistical test on the summation, the results
an be misleading due to the fact that the same event will be
ver-counted because of high shared mutual information across
ndpoints. This is a salient feature of developmental assays, where
ome key event(s) can trigger many observable phenotypes. Fifth,
ggE can be applied to datasets of varying size, complexity, and
egree of non-independence, since its threshold is a function of
bserved incidences over many individuals. We  have demonstrated
ts use in a high-dimensional zebraﬁsh development assay, but this
ethod could be applied to multiplexed measurements in other
n vitro or in vivo systems, or even to binarized “hits” from assay
uites, gene expression, or pathway enrichment analysis.
. ConclusionsIn summary, we developed a new computational approach to
haracterize chemical exposure information and applied it scoring
ultiplexed, phenotypic endpoints measured in zebraﬁsh (Daniorerio) across several concentrations. We  were able to elucidate
multi-endpoint syndromes across related endpoints as well as
identify chemicals that displayed generalized teratogenic effects.
As a complement to rank-based [10], curve-ﬁtting [11], and a priori
weighting metrics [12], AggE is a ﬂexible approach that is capable of
identifying hazardous chemicals from data encompassing a broad
parameter space, while avoiding many statistical pitfalls of tradi-
tional methods. By testing AggE in a variety of high-dimensional
real and simulated datasets, we have characterized its performance
and suggested implementation parameters that can guide its appli-
cation across a wide range of experimental scenarios.
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